Log in or Sign up for Free to view tailored content for your specialty!
Cutaneous Oncology News
Top news of July: Permanent makeup, FDA approvals, tattoos, more
Healio has compiled July’s most-read news in dermatology.
‘Make it a habit’: Expert stresses need to incorporate sun protection into daily routine
In this video, Hansa Bhargava, MD, and Victoria Barbosa, MD, MPH, MBA, FAAD, discuss the impact of UV rays on aging and the risk for skin cancer, as well as ways to protect your skin from the sun.
Log in or Sign up for Free to view tailored content for your specialty!
Immunotherapy combination improves response in unresectable melanoma
An immunotherapy combination improved outcomes compared with historical control for certain patients with advanced melanoma, according to a topline data announcement.
American Skin Association research grant recipients to target psoriasis, vitiligo, more
The American Skin Association has announced the recipients of its 2024 research grants for skin cancer and diseases, according to a press release.
CBD cream prevents, repairs skin damage from the sun, but not sunscreen substitute
Topically applied nanoparticle-encapsulated cannabidiol cream helped prevent and repair damage to the skin from ultraviolet A radiation, according to a first-of-its-kind study.
New radiation therapy guidelines for nonmelanoma skin cancer stress multidisciplinary care
The Dermatology Association of Radiation Therapy has announced new guidelines for the treatment of nonmelanoma skin cancer, according to an association press release.
Q&A: On National Tattoo Day, dermatologist talks history, uses, risks of longtime art form
While the art of tattooing has been present for centuries, the medical implications are only recently coming to light with modern medicine.
Moisturizer with sunscreen blends well, exhibits good cosmetic outcomes in skin of color
A facial moisturizer that contains sunscreen did not leave a white cast on individuals with skin of color, providing a formulation that will encourage sun protection, according to a study.
HyBryte exhibits positive outcomes in early-stage cutaneous T-cell lymphoma
New interim results showed that HyBryte treatment demonstrated positive outcomes in patients with early-stage cutaneous T-cell lymphoma, according to a Soligenix press release.
Nearly half of cancer deaths among U.S. adults attributable to modifiable risk factors
About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read